AtriCure (ATRC) CTO awarded 45,588 shares, withholds 13,127 for tax

Rhea-AI Filing Summary

AtriCure, Inc. Chief Technical Officer Salvatore Privitera reported equity compensation activity involving company common stock. He acquired 30,390 shares on March 1, 2026 through a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan, with one third of the shares vesting on each of the first, second, and third anniversaries of the grant date. He also acquired 15,198 shares on the same date from the vesting and release of a Performance Share Award under the same plan after company performance goals and service requirements were met. To cover tax withholding obligations related to vesting and release of prior awards, he transferred 13,127 shares back to the company at $31.26 per share, and directly owned 158,048 shares after these transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Privitera Salvatore

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OH 45040-9695

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		A		30,390	A	$0(1)	155,977	D
Common Stock	03/01/2026		A		15,198	A	$0(2)	171,175	D
Common Stock	03/01/2026		F		13,127(3)	D	$31.26	158,048	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

2. The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

3. The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Remarks:

	/s/ Salvatore Privitera	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AtriCure (ATRC) CTO Salvatore Privitera report?

Salvatore Privitera reported equity compensation activity, including two stock acquisitions and one disposition. He received restricted and performance-based stock awards and transferred some shares back to AtriCure to satisfy tax withholding obligations related to vesting of prior awards.

How many AtriCure (ATRC) shares did the CTO acquire and dispose in this Form 4?

He acquired 30,390 shares via a Restricted Stock Award and 15,198 shares from a Performance Share Award vesting. He then transferred 13,127 shares back to AtriCure to cover tax withholding, as reflected by a tax-withholding disposition transaction.

What is the vesting schedule for Salvatore Privitera’s new AtriCure (ATRC) Restricted Stock Award?

The Restricted Stock Award for 30,390 shares vests in three equal portions. One third of the shares vest on each of the one, two, and three year anniversaries of the March 1, 2026 grant date under AtriCure’s 2023 Stock Incentive Plan.

What performance conditions applied to the AtriCure (ATRC) Performance Share Award that vested?

The Performance Share Award that delivered 15,198 shares had company performance goals and a service period requirement. Both conditions were satisfied, leading to the vesting and release of shares to Salvatore Privitera under the 2023 Stock Incentive Plan.

Why did the AtriCure (ATRC) CTO transfer 13,127 shares back to the company?

He elected to transfer 13,127 shares to AtriCure to satisfy tax withholding obligations. These obligations arose upon the vesting and release of shares previously acquired through Restricted Stock Awards or Performance Share Awards, and the transfer is recorded as a tax-withholding disposition.

How many AtriCure (ATRC) shares did Salvatore Privitera own after these transactions?

After the reported grant, vesting, and tax-withholding disposition, Salvatore Privitera directly owned 158,048 shares of AtriCure common stock. This figure reflects his holdings following the March 1, 2026 transactions disclosed in the Form 4 filing.